The Horizons Tracker
NOVEMBER 7, 2019
But if as a nation we want to make sure that today’s new technologies evolve in ways that help build a healthier, more equitable society, we need to move quickly to develop and implement strong, enlightened policy responses,” the authors say. in 2013, with this resulting in the stagnating wages we’re seeing today.
Harvard Business Review
MAY 12, 2014
In developed economies, they have even sparked a trend toward the return of jobs from overseas, or “botsourcing.” The more processes can be automated, the less it makes sense to outsource activities to countries where labor is less expensive. The threat is being taken seriously elsewhere in Asia as well. last year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
JUNE 5, 2018
” Technological developments are often interesting to discuss in relation to relevance. For instance, numerous smartphone apps have been developed that do not solve any actual problems. At that time, many consumers adopted a new level of frugality , such that they took on previously outsourced tasks and became more self-reliant.
Harvard Business Review
SEPTEMBER 23, 2016
Successfully identifying, developing, and retaining leadership talent is critical for any organization’s long-term success. According to a 2013 CEB study , “only one in four HR organizations have effectively integrated their talent management practices…with the company’s strategic objectives.”
Harvard Business Review
MAY 14, 2013
Although the Border Security, Economic Opportunity, and Immigration Modernization Bill of 2013 — introduced four weeks ago by a bipartisan group of eight U.S. For some time now, it has been obvious that these companies will have to go beyond the offshoring model that served them well in the past and develop innovative new ones.
Harvard Business Review
NOVEMBER 4, 2014
Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. Even the U.S. Even the U.S.
Harvard Business Review
NOVEMBER 4, 2014
Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. Even the U.S. Even the U.S.
Expert insights. Personalized for you.
46 
Let's personalize your content